Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
4.740
+0.810 (20.61%)
At close: Jul 15, 2026, 4:00 PM EDT
4.690
-0.050 (-1.05%)
After-hours: Jul 15, 2026, 7:59 PM EDT
Iovance Biotherapeutics Employees
Iovance Biotherapeutics had 975 employees as of December 31, 2025. The number of employees increased by 137 or 16.35% compared to the previous year.
Employees
975
Change (1Y)
137
Growth (1Y)
16.35%
Revenue / Employee
$292,931
Profits / Employee
-$362,933
Market Cap
2.12B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 975 | 137 | 16.35% |
| Dec 31, 2024 | 838 | 281 | 50.45% |
| Dec 31, 2023 | 557 | 54 | 10.74% |
| Dec 31, 2022 | 503 | 184 | 57.68% |
| Dec 31, 2021 | 319 | 78 | 32.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Intellia Therapeutics | 377 |
| Zymeworks | 243 |
| Monte Rosa Therapeutics | 187 |
| Stoke Therapeutics | 170 |
| Zenas BioPharma | 167 |
| Precigen | 160 |
| Bicara Therapeutics | 103 |
IOVA News
- 15 days ago - Iovance Biotherapeutics Slides: Corporate presentation - Filings
- 26 days ago - Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 27 days ago - Iovance Biotherapeutics files automatic mixed securities shelf - TheFly
- 5 weeks ago - Iovance Biotherapeutics Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Iovance Biotherapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 6 weeks ago - Iovance receives Australian approval of Amtagvi for advanced melanoma - TheFly
- 6 weeks ago - Iovance's Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia - GlobeNewsWire
- 6 weeks ago - Iovance gets allowance to proceed from FDA for IOV-5001 IND application - TheFly